Epineuron, a clinical-stage nerve care company, recently announced that it has successfully enrolled the first patient in the company’s pivotal trial, REGAIN™. This is a huge milestone for Epineuron and a step towards advancing better care for the treatment of injured peripheral nerves.
Epineuron is an alumnus of OBIO’s BDSP™, CAAP® , H2BB™ and WiHI programs.